More about

Idiopathic Hypersomnia

News
June 12, 2024
5 min watch
Save

VIDEO: Higher odds of comorbidities in those with idiopathic hypersomnia

DENVER — Patients with idiopathic hypersomnia have higher odds of comorbidities both related and unrelated to sleep, Jed Black, MD, says in this Healio video from the American Academy of Neurology annual meeting.

CME
Video

Pay It Forward: Bridging the Gaps Between Payers and Providers to Get the Medication Your Patient Needs When They Need It for Narcolepsy and Idiopathic Hypersomnia

0.75 CME
0.75 CPE
45 MINS
$0 FEE
News
June 29, 2023
2 min watch
Save

VIDEO: Xywav improves symptoms of idiopathic hypersomnia, even severe sleep inertia

INDIANAPOLIS — Treatment with Xywav was effective in addressing symptoms of idiopathic hypersomnia, regardless of baseline sleep inertia severity, according to Marisa Whalen, PharmD, in this Healio video from SLEEP 2023.

News
March 22, 2023
4 min read
Save

Despite current therapies, challenges remain when treating excessive daytime sleepiness

Excessive daytime sleepiness is a common symptom of several sleep disorders, including obstructive sleep apnea, which is estimated to affect 10% to 30% of adults in the U.S and often goes underdiagnosed, according to the Sleep Foundation.

News
June 22, 2022
1 min read
Save

Q&A: Jazz Pharmaceuticals, Sumitomo Pharma to partner on oral treatment for narcolepsy

Jazz Pharmaceuticals announced it has entered into a licensing agreement with Sumitomo Pharma Co. to develop and commercialize an oral treatment for narcolepsy, idiopathic hypersomnia and other sleep disorders.

News
June 09, 2022
2 min watch
Save

VIDEO: Lower-sodium oxybate just as safe as oxybate for idiopathic hypersomnia

CHARLOTTE, N.C. – The side effect profile of lower-sodium oxybate was similar to that seen in previous sodium oxybate trials when being used to treat idiopathic hypersomnia, Richard K. Bogan, MD, FCCP, FAASM, said at SLEEP 2022.

News
October 22, 2021
2 min read
Save

LXB improves functional outcomes in patients with idiopathic hypersomnia

LXB improved all measures of function and work productivity among patients with idiopathic hypersomnia, according to findings presented at the American Neurological Association Annual Meeting.